Nutcracker Therapeutics Stock
HealthTechLooking to sell Nutcracker Therapeutics stock or options?
Eligible for:
Charitable Exchange Fund
Nutcracker Therapeutics has developed a biotech platform that is designed to create mRNA-based therapeutic drug products. The company's platform integrates proprietary hardware and software with advancements in mRNA biochemistry and nanoparticle delivery to produce optimized therapies on biochips. This enables medical professionals to discover, develop, and manufacture complex mRNA therapies and vaccines, which can greatly enhance human health.
Investors Include:
Bluebird Ventures, ND Capital, A&E Investments, Altitude Life Science Ventures, ARCH Venture Partners, Qatar Investment Authority.